Telix

Therapeutics
Therapeutics
Current

Initial Transaction Details

Transaction Date
April 2024
Purpose of Financing
Stage of Company
Structure of Financing

Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices.

Original transaction with ARTMS in May 2020.

Website